NIH-funded research R01 grant

A system to detect DNA mutations that affect health and disease

Official title: MutSensor System: A Set of Highly Sensitive Mutation Reporters to Dissect Genome Stability in Health and Disease

Funded at New York University School of Medicine · NIH-10930104 · Data updated 2026-11-12

This study is looking at how changes in our DNA happen in human cells and how these changes can lead to diseases like cancer, using a new tool called MutSensor to get better measurements, which could help us understand and fix these mutations.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 15, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$743,249
NIH project number5R01HG012590-02
Project IDNIH-10930104 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a family history of cancer or those diagnosed with conditions related to DNA mutations.

Less likely to help

Patients with no known genetic predisposition to mutations or those without a history of related diseases may not benefit from this research.

What this research studies

This research focuses on understanding how DNA mutations occur in human cells and their role in diseases like cancer. By developing a new tool called MutSensor, the researchers aim to measure DNA mutation rates with much greater sensitivity than current methods. This innovative approach will allow them to identify the genetic factors that influence mutation frequency across different cell types in the human body. The findings could provide crucial insights into how mutations contribute to various diseases and how they can be repaired.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potentially new treatments for diseases caused by DNA mutations, including cancer.

How similar studies have gone: Other research has shown success in using advanced genetic tools to study mutations, making this approach promising yet innovative.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Davoli, Teresa — New York University School of Medicine
  • Study coordinator: Davoli, Teresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.